04 Oct 2025
Case Details
AI Cases For
Fresha Health
Patient-Centric Rehabilitation with Doctor-in-the-Loop
FresaHealth delivers patient-centric rehabilitation by combining AI-driven personalized care with direct oversight from doctors, enabling effective recovery at home.
Executive Summary
Re-hospitalization due to lack of timely Patient Rehabilitation and low Treatment Adherence at home is a $92 Billion problem worldwide. Fresa Health is at the forefront of transforming rehabilitation care through a patient-centric approach, integrating healthcare providers with advanced Artificial Intelligence to care for patients remotely, create custom treatment pathways. Their model focuses on enabling patients to recover effectively at home, supported remotely by medical professionals and intelligent systems that create personalized journeys within therapeutic boundaries. Thousands of patients rely on this digital rehabilitation for mental health, orthopaedic and cardiac wellness.
This case study explores the critical need for such innovative solutions, the specifics of Fresa Health's offering that Questa built, and the robust regulatory framework that underpins its quality and trustworthiness.
Table Of Contents
1. Executive Summary
2. Business Problem
3. Platform Built
4. How Fresha Health Works
5. Regulatory Compliance
6. Scaling Personalized Treatment
7. References
Table Of Contents
1. Executive Summary
2.Business Problem
3.Platform Built
4.How Fresha Health Works
5.Regulatory Compliance
6.Scaling Personalized Treatment
7.References
Have any Questions?
Call us Today !
+0(123)456-789
Business Problem: Economic & Patient Experience Burden
Traditional rehabilitation programs often face significant challenges, leading to suboptimal patient outcomes and substantial economic burdens on healthcare systems. A key issue is the high rate and cost of rehospitalization, which places immense strain on resources across Europe and globally.
Market research data consistently highlights the fiscal impact of rehospitalizations. For instance, a 16-year nationwide study in Portugal focusing on inflammatory bowel disease (IBD) revealed that 33% of IBD-related hospitalizations were rehospitalizations. The mean IBD-related rehospitalization charges escalated from €14,589 per hospitalization-year in 2000 to €17,548 in 2015, with total annual rehospitalization costs reaching €3.1 million by 2015 for IBD alone.
In Germany, psychiatric inpatient care remains a major component of treatment for mental disorders, though there has been development of outpatient, day‐hospital, and community psychiatric services but still not enough remote rehabilitation services.
One study observed that from 1991 to 2010,—while the number of psychiatric beds decreased and average length of stay dropped (from ~65 days to ~23 days), the number of people receiving inpatient psychiatric care almost doubled. Over a similar period, the rehospitalization rate rose leading to almost €29 Billion additional re-hospitalization costs.
Beyond the financial aspect, current rehabilitation models often leave patients feeling unsupported, overwhelm doctors with excessive requests, and frequently result in incomplete recoveries. Fresa Health identifies these critical gaps:
One study observed that from 1991 to 2010,—while the number of psychiatric beds decreased and average length of stay dropped (from ~65 days to ~23 days), the number of people receiving inpatient psychiatric care almost doubled. Over a similar period, the rehospitalization rate rose leading to almost €29 Billion additional re-hospitalization costs.
Beyond the financial aspect, current rehabilitation models often leave patients feeling unsupported, overwhelm doctors with excessive requests, and frequently result in incomplete recoveries. Fresa Health identifies these critical gaps: